Profile data is unavailable for this security.
About the company
PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.
- Revenue in USD (TTM)274.56m
- Net income in USD26.41m
- Incorporated1996
- Employees199.00
- LocationPetmed Express Inc420 S Congress AveDELRAY BEACH 33445-4693United StatesUSA
- Phone+1 (561) 426-4444
- Fax+1 (800) 600-8285
- Websitehttps://www.1800petmeds.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taxus Pharmaceuticals Holdings Inc | 500.00 | -51.42k | 258.36m | -- | -- | -- | -- | 516,711.30 | -0.0008 | -0.0008 | 0.00001 | -0.0002 | 0.0676 | -- | -- | -- | -694.86 | -- | -- | -- | -4,052.00 | -- | -10,284.00 | -- | -- | -- | -- | -- | -90.44 | -- | 56.24 | -- | -- | -- |
| HLS Therapeutics Inc | 56.88m | -6.96m | 401.72m | 525.00 | -- | 2.13 | 15.80 | 7.06 | -0.3233 | -0.3233 | 2.64 | 8.11 | 0.1761 | 1.07 | 4.22 | -- | -2.16 | -3.00 | -2.44 | -3.37 | 96.41 | -- | -12.24 | -9.48 | 1.73 | 0.142 | 0.3334 | -- | -18.20 | -5.65 | -306.86 | -- | 8.99 | -30.92 |
| Rite Aid Corporation | 21.57bn | -450.92m | 443.39m | 53.10k | -- | 0.4618 | -- | 0.0206 | -8.51 | -8.62 | 407.19 | 17.50 | 2.29 | 8.88 | 10.82 | 406,187.50 | -4.79 | 3.18 | -6.79 | 4.55 | 21.41 | 23.89 | -2.09 | 1.34 | 0.845 | 0.4801 | 0.8011 | 0.00 | 0.5137 | -3.25 | -2,592.91 | -- | -10.29 | -- |
| Petmed Express Inc | 274.56m | 26.41m | 467.25m | 199.00 | 17.81 | 3.72 | 16.30 | 1.70 | 1.30 | 1.30 | 13.52 | 6.23 | 1.87 | 8.08 | 168.85 | 1,379,683.00 | 17.99 | 25.02 | 20.48 | 28.42 | 29.85 | 33.45 | 9.62 | 10.58 | 5.35 | -- | 0.00 | 62.02 | 3.51 | 3.96 | 8.44 | 16.00 | 68.98 | 9.94 |
| Homology Medicines Inc | 2.08m | -98.75m | 817.72m | 184.00 | -- | 3.17 | -- | 392.57 | -2.43 | -2.43 | 0.0514 | 5.87 | 0.0071 | -- | -- | 16,798.39 | -33.75 | -- | -36.05 | -- | -- | -- | -4,740.78 | -- | -- | -- | 0.00 | -- | -- | -- | -90.77 | -- | -- | -- |
| Prestige Consumer Healthcare Inc | 952.66m | -33.93m | 1.96bn | 520.00 | -- | 1.76 | -- | 2.06 | -0.6454 | -0.6454 | 18.41 | 22.15 | 0.266 | 3.37 | 6.43 | 1,832,044.00 | -0.9474 | 1.78 | -0.9878 | 1.85 | 57.55 | 56.78 | -3.56 | 6.40 | 1.22 | 2.90 | 0.6119 | 0.00 | -6.28 | 10.31 | -150.23 | -- | 30.55 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2019 | 2.87m | 14.24% |
| Renaissance Technologies LLCas of 30 Sep 2019 | 1.62m | 8.04% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 1.38m | 6.83% |
| Dimensional Fund Advisors LPas of 30 Sep 2019 | 866.93k | 4.30% |
| SSgA Funds Management, Inc.as of 30 Sep 2019 | 853.32k | 4.23% |
| SG Americas Securities LLCas of 30 Sep 2019 | 677.50k | 3.36% |
| BofA Securities, Inc.as of 30 Sep 2019 | 588.90k | 2.92% |
| Numeric Investors LLCas of 30 Sep 2019 | 546.57k | 2.71% |
| Newtyn Management LLCas of 30 Sep 2019 | 526.00k | 2.61% |
| Penserra Capital Management LLCas of 30 Sep 2019 | 450.32k | 2.23% |
